Loading…

Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs

The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atrop...

Full description

Saved in:
Bibliographic Details
Published in:Neuropharmacology 2005-09, Vol.49 (3), p.293-299
Main Authors: Enginar, Nurhan, Nurten, Asiye, Yamantürk Çelik, Pınar, Açıkmeşe, Barış
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613
cites
container_end_page 299
container_issue 3
container_start_page 293
container_title Neuropharmacology
container_volume 49
creator Enginar, Nurhan
Nurten, Asiye
Yamantürk Çelik, Pınar
Açıkmeşe, Barış
description The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs.
doi_str_mv 10.1016/j.neuropharm.2005.01.032
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17457594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390805001474</els_id><sourcerecordid>17457594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613</originalsourceid><addsrcrecordid>eNqFkcFu1DAURS0Eaqelv4C8YkXCc-IkNjuoaEGqxAJYW479XDwk9mAnI_Uj-GfcTqQuWdl69z5f-R5CKIOaAevf7-uAa4qHXzrNdQPQ1cBqaJsXZMfE0FYD9Pwl2QE0omoliHNykfMeALhg4oycs04yyaDZkb_fTTzESc8-YOWDXQ1aamI4rlP2MWTqA3U6L2U6e4NUuwUTdTHaoiz6N36g6ByaJdPo6P20mphxk95RHRY_r9no5IM3VJvFH_3yUOb2SduCypXatN7n1-SV01PGq-28JD9vPv-4_lLdfbv9ev3xrjIc2qWyQrYIpQnkHJ2Gbmz6dpC9to0dxr7rpZGD0E6MvJMWBsFazcVoR2v6Uh9rL8nb07uHFP-smBc1-2xwmnTAuGbFBt4NneTFKE5Gk2LOCZ06JD_r9KAYqEcUaq-eUahHFAqYKijK6pstYx1ntM-LW_fF8OlkwPLTo8eksvEYCgCfSqHKRv__lH9nbqN3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17457594</pqid></control><display><type>article</type><title>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</title><source>Elsevier</source><creator>Enginar, Nurhan ; Nurten, Asiye ; Yamantürk Çelik, Pınar ; Açıkmeşe, Barış</creator><creatorcontrib>Enginar, Nurhan ; Nurten, Asiye ; Yamantürk Çelik, Pınar ; Açıkmeşe, Barış</creatorcontrib><description>The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2005.01.032</identifier><identifier>PMID: 15919102</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Anticonvulsants ; Anticonvulsants - administration &amp; dosage ; Anticonvulsants - pharmacology ; Antimuscarinic activity ; Biperiden - pharmacology ; Eating - physiology ; Fasting ; Food intake ; Glucose - administration &amp; dosage ; Glucose - pharmacology ; Glucose intake ; Hypoglycemia - chemically induced ; Hypoglycemia - psychology ; Male ; Mice ; Mice, Inbred BALB C ; Muscarinic Antagonists - pharmacology ; Myoclonus - chemically induced ; Myoclonus - physiopathology ; Scopolamine Hydrobromide - pharmacology ; Scopolamine-induced convulsions ; Seizures - chemically induced</subject><ispartof>Neuropharmacology, 2005-09, Vol.49 (3), p.293-299</ispartof><rights>2005 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15919102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Enginar, Nurhan</creatorcontrib><creatorcontrib>Nurten, Asiye</creatorcontrib><creatorcontrib>Yamantürk Çelik, Pınar</creatorcontrib><creatorcontrib>Açıkmeşe, Barış</creatorcontrib><title>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs.</description><subject>Animals</subject><subject>Anticonvulsants</subject><subject>Anticonvulsants - administration &amp; dosage</subject><subject>Anticonvulsants - pharmacology</subject><subject>Antimuscarinic activity</subject><subject>Biperiden - pharmacology</subject><subject>Eating - physiology</subject><subject>Fasting</subject><subject>Food intake</subject><subject>Glucose - administration &amp; dosage</subject><subject>Glucose - pharmacology</subject><subject>Glucose intake</subject><subject>Hypoglycemia - chemically induced</subject><subject>Hypoglycemia - psychology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Muscarinic Antagonists - pharmacology</subject><subject>Myoclonus - chemically induced</subject><subject>Myoclonus - physiopathology</subject><subject>Scopolamine Hydrobromide - pharmacology</subject><subject>Scopolamine-induced convulsions</subject><subject>Seizures - chemically induced</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkcFu1DAURS0Eaqelv4C8YkXCc-IkNjuoaEGqxAJYW479XDwk9mAnI_Uj-GfcTqQuWdl69z5f-R5CKIOaAevf7-uAa4qHXzrNdQPQ1cBqaJsXZMfE0FYD9Pwl2QE0omoliHNykfMeALhg4oycs04yyaDZkb_fTTzESc8-YOWDXQ1aamI4rlP2MWTqA3U6L2U6e4NUuwUTdTHaoiz6N36g6ByaJdPo6P20mphxk95RHRY_r9no5IM3VJvFH_3yUOb2SduCypXatN7n1-SV01PGq-28JD9vPv-4_lLdfbv9ev3xrjIc2qWyQrYIpQnkHJ2Gbmz6dpC9to0dxr7rpZGD0E6MvJMWBsFazcVoR2v6Uh9rL8nb07uHFP-smBc1-2xwmnTAuGbFBt4NneTFKE5Gk2LOCZ06JD_r9KAYqEcUaq-eUahHFAqYKijK6pstYx1ntM-LW_fF8OlkwPLTo8eksvEYCgCfSqHKRv__lH9nbqN3</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Enginar, Nurhan</creator><creator>Nurten, Asiye</creator><creator>Yamantürk Çelik, Pınar</creator><creator>Açıkmeşe, Barış</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20050901</creationdate><title>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</title><author>Enginar, Nurhan ; Nurten, Asiye ; Yamantürk Çelik, Pınar ; Açıkmeşe, Barış</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Anticonvulsants</topic><topic>Anticonvulsants - administration &amp; dosage</topic><topic>Anticonvulsants - pharmacology</topic><topic>Antimuscarinic activity</topic><topic>Biperiden - pharmacology</topic><topic>Eating - physiology</topic><topic>Fasting</topic><topic>Food intake</topic><topic>Glucose - administration &amp; dosage</topic><topic>Glucose - pharmacology</topic><topic>Glucose intake</topic><topic>Hypoglycemia - chemically induced</topic><topic>Hypoglycemia - psychology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Muscarinic Antagonists - pharmacology</topic><topic>Myoclonus - chemically induced</topic><topic>Myoclonus - physiopathology</topic><topic>Scopolamine Hydrobromide - pharmacology</topic><topic>Scopolamine-induced convulsions</topic><topic>Seizures - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Enginar, Nurhan</creatorcontrib><creatorcontrib>Nurten, Asiye</creatorcontrib><creatorcontrib>Yamantürk Çelik, Pınar</creatorcontrib><creatorcontrib>Açıkmeşe, Barış</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Enginar, Nurhan</au><au>Nurten, Asiye</au><au>Yamantürk Çelik, Pınar</au><au>Açıkmeşe, Barış</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>49</volume><issue>3</issue><spage>293</spage><epage>299</epage><pages>293-299</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>The present study was performed to further evaluate the contribution of antimuscarinic activity and hypoglycaemia to the development of scopolamine-induced convulsions in fasted mice after food intake. The effects of anticonvulsant drugs on convulsions were also evaluated. Antimuscarinic drugs atropine (3 mg/kg) and biperiden (10 mg/kg) were given intraperitoneally (i.p) to animals fasted for 48 h. Like scopolamine, both drugs induced convulsions after animals were allowed to eat ad libitum. Another group of animals was given glucose (5%) in drinking water during fasting. These animals, although they had normoglycaemic blood levels after fasting, also developed convulsions after treated with scopolamine i.p. (3 mg/kg), atropine (3 mg/kg) or biperiden (10 mg/kg) and allowed to eat ad libitum. Among the drugs studied, only valproate (340 mg/kg), gabapentin (50 mg/kg) and diazepam (2.5 and 5 mg/kg) markedly reduced the incidence of scopolamine-induced convulsions. The present results indicate that antimuscarinic activity, but not hypoglycaemia, underlies these convulsions which do not respond to most of the conventional anticonvulsant drugs.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15919102</pmid><doi>10.1016/j.neuropharm.2005.01.032</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 2005-09, Vol.49 (3), p.293-299
issn 0028-3908
1873-7064
language eng
recordid cdi_proquest_miscellaneous_17457594
source Elsevier
subjects Animals
Anticonvulsants
Anticonvulsants - administration & dosage
Anticonvulsants - pharmacology
Antimuscarinic activity
Biperiden - pharmacology
Eating - physiology
Fasting
Food intake
Glucose - administration & dosage
Glucose - pharmacology
Glucose intake
Hypoglycemia - chemically induced
Hypoglycemia - psychology
Male
Mice
Mice, Inbred BALB C
Muscarinic Antagonists - pharmacology
Myoclonus - chemically induced
Myoclonus - physiopathology
Scopolamine Hydrobromide - pharmacology
Scopolamine-induced convulsions
Seizures - chemically induced
title Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A15%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Scopolamine-induced%20convulsions%20in%20fasted%20mice%20after%20food%20intake:%20effects%20of%20glucose%20intake,%20antimuscarinic%20activity%20and%20anticonvulsant%20drugs&rft.jtitle=Neuropharmacology&rft.au=Enginar,%20Nurhan&rft.date=2005-09-01&rft.volume=49&rft.issue=3&rft.spage=293&rft.epage=299&rft.pages=293-299&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2005.01.032&rft_dat=%3Cproquest_cross%3E17457594%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-d893e0101e44efa05b263796ad2d7b6569c978af8b459d07813a48bdbdc601613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17457594&rft_id=info:pmid/15919102&rfr_iscdi=true